Matthias Wiedenfels

Matthias Wiedenfels

Presidente en APONTIS PHARMA AG .
53 años
Health Technology
Consumer Services
Finance

Perfil

Matthias Wiedenfels is Chief Executive Officer at BioCopy AG since 2023.
Holds the position of Chairman-Supervisory Board at APONTIS PHARMA AG since 2021.
Serves as Managing Director at Digithep GmbH.
Member of the Management Board at STADA Lux SARL. Member of the Supervisory Board at Spirig HealthCare AG, Pegach AG, Healgen Medical AG, and Biomedion Holding GmbH.
Formerly Chairman-Executive Board and Chief Executive Officer at STADA. Arzneimittel AG from 2016 to 2017.
Former Chief Executive Officer at Perspix Biotech GmbH.
Former Attorney at Ashurst LLP.
Former Member of the Management Board at BioMedion GmbH.
Education includes a doctorate from the University of Freiburg, and graduate degrees from Université de Montpellier and Ruprecht-Karls-Universität Heidelberg.

Cargos activos de Matthias Wiedenfels

EmpresasCargoInicio
APONTIS PHARMA AG Presidente -
Corporate Officer/Principal -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Healgen Medical AG
Director/Miembro de la Junta -
Digithep GmbH
Director Ejecutivo -
Director/Miembro de la Junta -
Director Ejecutivo 01/10/2023

Antiguos cargos conocidos de Matthias Wiedenfels.

EmpresasCargoFin
STADA ARZNEIMITTEL Director Ejecutivo 04/07/2017
░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Ver el detalle de la experiencia de Matthias Wiedenfels.

Formación de Matthias Wiedenfels.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

28

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Technology Services

Finance

Health Technology

Finance

Health Technology

Health Technology

Healgen Medical AG

Digithep GmbH

Perspix Biotech GmbH

Miscellaneous

  1. Bolsa de valores
  2. Insiders
  3. Matthias Wiedenfels
-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN